ABSTRACT
Subject(s)
Animals , Humans , Bacterial Proteins/physiology , Caenorhabditis elegans/physiology , Corynebacterium diphtheriae/pathogenicity , Epithelial Cells/microbiology , Tellurium/pharmacology , Virulence Factors/physiology , Anti-Bacterial Agents/pharmacology , Bacterial Adhesion , Caenorhabditis elegans/microbiology , Corynebacterium diphtheriae/drug effects , Microbial Sensitivity Tests , VirulenceABSTRACT
The increasing problems with multidrug resistance in relation to Corynebacterium, including C. diphtheriae, are examples of challenges confronting many countries. For this reason, Brazilian C. diphtheriae strains were evaluated by the E-Test for their susceptibility to nine antibacterial drugs used in therapy. Resistance (MIC < 0.002; 0.38 µg/ml) to penicillin G was found in 14.8 percent of the strains tested. Although erythromycin (MIC90 0.75 µg/ml) and azithromycin (MIC90 0.064 µg/ml) were active against C. diphtheriae in this study, 4.2 percent of the strains showed decreased susceptibility (MIC 1.0 µg/ml) to erythromycin. Multiple resistance profiles were determined by the disk diffusion method using 31 antibiotics. Most C. diphtheriae strains (95.74 percent) showed resistance to mupirocin, aztreonam, ceftazidime, and/or oxacillin, ampicillin, penicillin, tetracycline, clindamycin, lincomycin, and erythromycin. This study presents the antimicrobial susceptibility profiles of Brazilian C. diphtheriae isolates. The data are of value to practitioners, and suggest that some concern exists regarding the use of penicillin.
Subject(s)
Anti-Bacterial Agents/pharmacology , Corynebacterium diphtheriae/drug effects , Drug Resistance, Multiple, Bacterial/genetics , Brazil , Corynebacterium diphtheriae/genetics , Disk Diffusion Antimicrobial Tests , PhenotypeABSTRACT
The triumph of antibiotics over bacterial pathogens that has occurred in the latter half of this century looks increasingly threatened as we approach the new millennium. Increasing resistance in important pathogens such as Mycobacterium tuberculosis, Shigella, and Streptococcus pneumoniae threatens the lives of millions. The increasing problems with drug resistance in (C. diphtheriae, Salmonella typhi and the pneumococcus in Vietnam are presented as examples of the challenge confronting tropical countries.